- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Patrick Gleason, PharmD, Discusses the Current and Forthcoming Trends in Specialty Pharmacy Management
Patrick Gleason, PharmD, director of Health Outcomes, Prime Therapeutics, says there are many current and forthcoming trends in specialty pharmacy management.
Patrick Gleason, PharmD, director of Health Outcomes, Prime Therapeutics, says there are many current and forthcoming trends in specialty pharmacy management.
“If you don’t have a clear understanding of what your expenditures are through both the pharmacy and medical benefit, then you’re unable to make wise decisions,” said Dr Gleason
Future trends in specialty pharmacy must analyze specialty drug expenditures via both medical and pharmacy benefit, and then start to apply the pharmacy benefit management and med policy decisions that are integrated. For example, care or case management that is integrated with the health plan and pharmacy benefit manager is just one of the few services trending in specialty pharmacy management.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
